News and announcements

08.02.05
Atrial Fibrillation Device Start-Up Ablatrics Closes $5.5M Series A
Dow Jones News Wire
Ablatrics Inc., a medical device company focused on a minimally invasive treatment for atrial fibrillation, said it closed a $5.5 million Series A round. Existing investor Intersouth Partners led the round that also included new shareholders Massey Burch Ventures and Tall Oaks Capital. Intersouth's Managing General Partner Dennis Dougherty said the round closed in early July. Dougherty said about 50% of Ablatrics is now held by outside investors.

08.01.05
Hemocellular, Ablatrics collectively raise $8M for promising technologies
Triangle Business Journal
Two early-stage medical technology companies have raised a total of $8 million in first rounds of funding - a sign that investors have returned to backing novel technologies. Ablatrics Inc. has garnered $5.5 million from venture funds including Durham-based Intersouth Partners and Nashville, Tenn.-based Massey Burch Capital.

04.30.04
Venture mood brightens
News & Observer
Although the venture funding environment remains choppy, at least 19 Triangle companies are hoping to buck the tide. Executives from startups around the Triangle, trying to collectively raise as much as $150 million in private funding this year, met with more than 300 potential investors at a venture-capital conference this week in Chapel Hill. Ablatrics, Inc, an early-stage medical device start-up company based in Chapel Hill, is looking to raise $3.5 million in initial funding.

04.28.04
Ablatrics, Inc. presented its platform technology at the Venture 2004 Conference sponsored by the Council for Entrepreneurial Development (CED) held in Chapel Hill, NC. Ablatrics was showcased as the lead of 13 early-stage companies selected to present at the conference. Venture 2004 is the Southeast's premier venture financing conference, presented by CED with support from UNC Kenan-Flagler Business School and the National Venture Capital Association. Since 1999, CED Venture presenters have raised over $1.5 billion in venture capital.